{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:20:37Z","timestamp":1790248837272,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,11]]},"DOI":"10.7759\/cureus.92085","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:18:41Z","timestamp":1757625521000},"source":"Crossref","is-referenced-by-count":3,"title":["Evaluating Abdominal Obesity and BMI As Risk Factors for Diabetic Nephropathy in Patients With Type 2 Diabetes Mellitus: A Case-Control Study"],"prefix":"10.7759","author":[{"given":"Safiyyah","family":"Ubaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Osama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ubaid","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahir","family":"Ud Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Zohaib Ul Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-020-00650-3","article-title":"Global, regional and time-trend prevalence of central obesity: a systematic review and meta-analysis of 13.2 million subjects","volume":"35","author":"Wong MC","year":"2020","unstructured":"Wong MC, Huang J, Wang J, et al.. Global, regional and time-trend prevalence of central obesity: a systematic review and meta-analysis of 13.2 million subjects. Eur J Epidemiol. 2020, 35:673-683. 10.1007\/s10654-020-00650-3","journal-title":"Eur J Epidemiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00020-9","article-title":"A central body fat distribution is related to renal function impairment, even in lean subjects","volume":"41","author":"Pinto-Sietsma SJ","year":"2003","unstructured":"Pinto-Sietsma SJ, Navis G, Janssen WT, et al.. A central body fat distribution is related to renal function impairment, even in lean subjects. Am J kidney Dis Off J Natl Kidney Found. 2003, 41:733-741. 10.1016\/S0272-6386(03)00020-9","journal-title":"Am J kidney Dis Off J Natl Kidney Found"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-1-200601030-00006","article-title":"Body mass index and risk for end-stage renal disease","volume":"144","author":"Hsu CY","year":"2006","unstructured":"Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006, 144:21-28. 10.7326\/0003-4819-144-1-200601030-00006","journal-title":"Ann Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-009-0245-8","article-title":"Involvement of visceral fat in the pathogenesis of albuminuria in patients with type 2 diabetes with early stage of nephropathy","volume":"14","author":"Hanai K","year":"2010","unstructured":"Hanai K, Babazono T, Nyumura I, et al.. Involvement of visceral fat in the pathogenesis of albuminuria in patients with type 2 diabetes with early stage of nephropathy. Clin Exp Nephrol. 2010, 14:132-136. 10.1007\/s10157-009-0245-8","journal-title":"Clin Exp Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000516391","article-title":"Meta-analysis of the relationship between abdominal obesity and diabetic kidney disease in type 2 diabetic patients","volume":"14","author":"Zhao Q","year":"2021","unstructured":"Zhao Q, Yi X, Wang Z. Meta-analysis of the relationship between abdominal obesity and diabetic kidney disease in type 2 diabetic patients. Obes Facts. 2021, 14:338-345. 10.1159\/000516391","journal-title":"Obes Facts"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2009.0133","article-title":"Prevalence of microalbuminuria among patients with type 2 diabetes mellitus--a hospital-based study from north India","volume":"12","author":"Kanakamani J","year":"2010","unstructured":"Kanakamani J, Ammini AC, Gupta N, Dwivedi SN. Prevalence of microalbuminuria among patients with type 2 diabetes mellitus--a hospital-based study from north India. Diabetes Technol Ther. 2010, 12:161-166. 10.1089\/dia.2009.0133","journal-title":"Diabetes Technol Ther"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1038\/s41387-017-0012-y","article-title":"Associations between body mass index and the risk of renal events in patients with type 2 diabetes","volume":"8","author":"Mohammedi K","year":"2018","unstructured":"Mohammedi K, Chalmers J, Herrington W, et al.. Associations between body mass index and the risk of renal events in patients with type 2 diabetes. Nutr Diabetes. 2018, 8:7.","journal-title":"Nutr Diabetes"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-020-01095-4","article-title":"Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference","volume":"19","author":"Wan H","year":"2020","unstructured":"Wan H, Wang Y, Xiang Q, et al.. Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference. Cardiovasc Diabetol. 2020, 19:118. 10.1186\/s12933-020-01095-4","journal-title":"Cardiovasc Diabetol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000041","article-title":"High body mass index reduces glomerular filtration rate decline in type II diabetes mellitus patients with stage 3 or 4 chronic kidney disease","volume":"93","author":"Huang WH","year":"2014","unstructured":"Huang WH, Chen CY, Lin JL, Lin-Tan DT, Hsu CW, Yen TH. High body mass index reduces glomerular filtration rate decline in type II diabetes mellitus patients with stage 3 or 4 chronic kidney disease. Medicine (Baltimore). 2014, 93:e41. 10.1097\/MD.0000000000000041","journal-title":"Medicine (Baltimore)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-0971","article-title":"Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry","volume":"31","author":"Luk AO","year":"2008","unstructured":"Luk AO, So WY, Ma RC, et al.. Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes Care. 2008, 31:2357-2361. 10.2337\/dc08-0971","journal-title":"Diabetes Care"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3109\/0886022X.2014.899472","article-title":"Does body mass index influence the decline of glomerular filtration rate in diabetic type 2 patients with diabetic nephropathy in a developing country?","volume":"36","author":"Bentata Y","year":"2014","unstructured":"Bentata Y, Latrech H, Abouqal R. Does body mass index influence the decline of glomerular filtration rate in diabetic type 2 patients with diabetic nephropathy in a developing country?. Ren Fail. 2014, 36:838-846. 10.3109\/0886022X.2014.899472","journal-title":"Ren Fail"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-021-00853-z","article-title":"Associations between obesity, weight change and decreased renal function in Korean type 2 diabetic patients: a longitudinal follow-up study","volume":"21","author":"Kim BY","year":"2021","unstructured":"Kim BY, Choi DH, Jung CH, Mok JO, Kim CH. Associations between obesity, weight change and decreased renal function in Korean type 2 diabetic patients: a longitudinal follow-up study. BMC Endocr Disord. 2021, 21:188. 10.1186\/s12902-021-00853-z","journal-title":"BMC Endocr Disord"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13736","article-title":"HbA1c-dependent projection of long-term renal outcomes","volume":"295","author":"Arnold F","year":"2024","unstructured":"Arnold F, Kappes J, Rottmann FA, Westermann L, Welte T. HbA1c-dependent projection of long-term renal outcomes. J Intern Med. 2024, 295:206-215. 10.1111\/joim.13736","journal-title":"J Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.673976","article-title":"The risk threshold for hemoglobin A1c associated with albuminuria: a population-based study in China","volume":"12","author":"Lian H","year":"2021","unstructured":"Lian H, Wu H, Ning J, et al.. The risk threshold for hemoglobin A1c associated with albuminuria: a population-based study in China. Front Endocrinol (Lausanne). 2021, 12:673976. 10.3389\/fendo.2021.673976","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4894","article-title":"HbA(1c) level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study","volume":"366","author":"Lind M","year":"2019","unstructured":"Lind M, Pivodic A, Svensson AM, \u00d3lafsd\u00f3ttir AF, Wedel H, Ludvigsson J. HbA(1c) level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study. BMJ. 2019, 366:l4894. 10.1136\/bmj.l4894","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1159\/000522280","article-title":"Impact of glucose tolerance and its change on incident proteinuria: analysis of a nationwide population-based dataset","volume":"53","author":"Suzuki Y","year":"2022","unstructured":"Suzuki Y, Kaneko H, Okada A, et al.. Impact of glucose tolerance and its change on incident proteinuria: analysis of a nationwide population-based dataset. Am J Nephrol. 2022, 53:307-315. 10.1159\/000522280","journal-title":"Am J Nephrol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-03948-4","article-title":"Remnant cholesterol and the risk of diabetic nephropathy progression to end-stage kidney disease in patients with type 2 diabetes mellitus: a longitudinal cohort study","volume":"86","author":"Zhao Y","year":"2024","unstructured":"Zhao Y, Liu K, Zou Y, et al.. Remnant cholesterol and the risk of diabetic nephropathy progression to end-stage kidney disease in patients with type 2 diabetes mellitus: a longitudinal cohort study. Endocrine. 2024, 86:994-1002. 10.1007\/s12020-024-03948-4","journal-title":"Endocrine"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10534-024-00626-w","article-title":"Evaluation of lipid profile, liver function enzymes, and trace elements in Iraqi diabetic nephropathy patients","volume":"37","author":"Zaid MH","year":"2024","unstructured":"Zaid MH, Al-Fartusie FS, Pazhang Y, Kader S. Evaluation of lipid profile, liver function enzymes, and trace elements in Iraqi diabetic nephropathy patients. Biometals. 2024, 37:1565-1574. 10.1007\/s10534-024-00626-w","journal-title":"Biometals"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-023-01526-9","article-title":"Lipid variability and risk of microvascular complications in patients with diabetes: a systematic review and meta-analysis","volume":"24","author":"Karimi MA","year":"2024","unstructured":"Karimi MA, Vaezi A, Ansari A, et al.. Lipid variability and risk of microvascular complications in patients with diabetes: a systematic review and meta-analysis. BMC Endocr Disord. 2024, 24:4. 10.1186\/s12902-023-01526-9","journal-title":"BMC Endocr Disord"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s41100-016-0028-0","article-title":"Dyslipidemia in diabetic nephropathy","volume":"2","author":"Kawanami D","year":"2016","unstructured":"Kawanami D, Matoba K, Utsunomiya K. Dyslipidemia in diabetic nephropathy. Ren Replace Ther. 2016, 2:16. 10.1186\/s41100-016-0028-0","journal-title":"Ren Replace Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.14660.1","article-title":"A systematic review comparing the evidence for kidney function outcomes between oral antidiabetic drugs for type 2 diabetes","volume":"3","author":"Wilkinson SV","year":"2018","unstructured":"Wilkinson SV, Tomlinson LA, Iwagami M, Stirnadel-Farrant HA, Smeeth L, Douglas I. A systematic review comparing the evidence for kidney function outcomes between oral antidiabetic drugs for type 2 diabetes. Wellcome Open Res. 2018, 3:74. 10.12688\/wellcomeopenres.14660.1","journal-title":"Wellcome Open Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-04012-x","article-title":"The impact of metformin on mortality in patients with type 2 diabetes mellitus: a prospective cohort study","volume":"87","author":"Zhang B","year":"2025","unstructured":"Zhang B, Cao Y, Qu Z, Sun Y, Tian X. The impact of metformin on mortality in patients with type 2 diabetes mellitus: a prospective cohort study. Endocrine. 2025, 87:136-143. 10.1007\/s12020-024-04012-x","journal-title":"Endocrine"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1890","article-title":"Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of kidney outcomes: emulation of a target trial using health care databases","volume":"43","author":"Xie Y","year":"2020","unstructured":"Xie Y, Bowe B, Gibson AK, McGill JB, Maddukuri G, Yan Y, Al-Aly Z. Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of kidney outcomes: emulation of a target trial using health care databases. Diabetes Care. 2020, 43:2859-2869. 10.2337\/dc20-1890","journal-title":"Diabetes Care"},{"key":"ref24","article-title":"Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk","volume":"38","author":"Fadini GP","year":"2024","unstructured":"Fadini GP, Longato E, Morieri ML, et al.. Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk. Lancet Reg Heal Eur. 2024, 38:100847.","journal-title":"Lancet Reg Heal Eur"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-024-02132-x","article-title":"Effect of DPP-4i inhibitors on renal function in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials","volume":"23","author":"Gong Y","year":"2024","unstructured":"Gong Y, Bai X, Zhang D, et al.. Effect of DPP-4i inhibitors on renal function in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Lipids Health Dis. 2024, 23:157. 10.1186\/s12944-024-02132-x","journal-title":"Lipids Health Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/408634-evaluating-abdominal-obesity-and-bmi-as-risk-factors-for-diabetic-nephropathy-in-patients-with-type-2-diabetes-mellitus-a-case-control-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:18:42Z","timestamp":1757625522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/408634-evaluating-abdominal-obesity-and-bmi-as-risk-factors-for-diabetic-nephropathy-in-patients-with-type-2-diabetes-mellitus-a-case-control-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.92085","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,11]]}}}